Cerebello-Cortical Connectivity and Balance Adaptation in Younger and Older Adults
Public ClinicalTrials.gov record NCT07901322. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cerebello-cortical Connectivity as an Adaptive Mechanism for Balance Control With Aging
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will investigate how communication between the cerebellum and cerebral cortex contributes to balance control and adaptation in younger and older adults. The study will enroll healthy younger adults ages 21-35 years and older adults ages 65-95 years. Participants will complete a single testing session that includes clinical balance assessments, transcranial magnetic stimulation (TMS), electroencephalography (EEG), electromyography (EMG), and reactive balance testing using an instrumented treadmill. Cerebello-cortical connectivity will be measured before and after reactive balance testing using cerebellar brain inhibition (CBI) and the cerebellar TMS-evoked potential P80. The study will examine how these measures relate to cortical activity, balance recovery, and adaptation across repeated perturbations, and whether these relationships differ between younger and older adults.
Study identification
- NCT ID
- NCT07901322
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 58 participants
Conditions and interventions
Conditions
Interventions
- Transcranial Magnetic Stimulation Assessment Device
- Reactive Balance Adaptation Task Behavioral
Device · Behavioral
Eligibility (public fields only)
- Age range
- 21 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2027 (Estimated)
- Primary completion
- Jul 1, 2028 (Estimated)
- Completion
- Sep 30, 2028 (Estimated)
- Last update posted
- Oct 28, 2026
2027 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota - Brains in Motion Laboratory, 426 Church Street SE, Room 219, Children's Rehabilitation Center | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07901322, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07901322 live on ClinicalTrials.gov.